The $1M Trial Is Real. So Is the Question It Can’t Answer.
Lindus Health ran a Phase 2a neurology trial for $1M. Impressive, but AI's cost wins are hiding the problem...
Lindus Health ran a Phase 2a neurology trial for $1M. Impressive, but AI's cost wins are hiding the problem...
More than half of physicians now use clinical AI regularly, but new data shows AI systems ordered tests at...
From a cancer patient's self-built AI agent to ARPA-H's phaseless trial model, AI has crossed from analytics into operations....
A Nature Biotechnology retinal AI model detects preeclampsia and gestational hypertension risk non-invasively, and its trial implications go far...
CDER's new Office of Innovation and Clinical Trial Modernization fuses AI and RWE policy under one roof. That structural...
CRScube acquired Mednet in Nov 2025, uniting 84,000 site users under one AI-assisted EDC. Here's what that means for...
Medable's CEO wants 90% of clinical trials automated by 2030. Site coordinators are still manually bridging 12 disconnected systems....
nPhase's AI clinical data platform promises smarter trial design, but before sponsors add another vendor, the activation-cycle math deserves...
A landmark Nature Medicine RCT found AI improved clinician decisions but not patient outcomes, exposing the fatal flaw in...
Scale AI's CliniCARE-Bench found 34.7% error rates and right-answer-wrong-process failures. The clinical trials field has no governance framework to...